Ligand Pharmaceuticals
Price & Volume
Stats
See moreOpen | $300.01 |
Previous Close | $301.81 |
Day Range | $300.01-$311.62 |
52W Range | $175.89-$326.63 |
Market Cap | $6B |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $290.5M |
Revenue Growth (YoY) | 33.7% |
Gross Profit (12 Mos) | $235.9M |
Diluted EPS | $9.49 |
News
See moreYahoo Finance • 14 days ago
Is Ligand Pharmaceuticals (LGND) Using AvenCell CAR-T Royalties To Redefine Its Cash-Flow Playbook?
Yahoo Finance • last month
Axsome Therapeutics vs. Viking Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?
Yahoo Finance • 2 months ago
Ligand Pharmaceuticals Highlights XOMA-Fueled Royalty Growth, $700M in Deployable Capital
Yahoo Finance • 2 months ago
Ligand Pharmaceuticals (LGND) Stock Trades Below Fair Value Following A 337% Run
About
CEO | Mr. Todd C. Davis Ph.D. |
Address | 555 Heritage Drive, Jupiter, FL, United States, 33458 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 47 |